Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southern California TMS Center
Corona/Riverside, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Southern California TMS Center is a leading provider of FDA-approved Transcranial Magnetic Stimulation (TMS), a non-invasive, non-systemic device-based therapy for depression and other mood disorders. The company has delivered over 200,000 treatments since its founding, with published outcomes in peer-reviewed journals[3]. TMS is positioned as an effective alternative for patients with treatment-resistant depression, with minimal side effects and without systemic medication[1][2].
- Therapeutic areas
- Psychiatry
- Modalities
- Device
- Industry
- Non-Academic Healthcare
Beyond the preview
Go deeper on Southern California TMS Center.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Southern California TMS Center.